Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.

Fettig LM, McGinn O, Finlay-Schultz J, LaBarbera DV, Nordeen SK, Sartorius CA.

Oncogene. 2017 Nov 2;36(44):6074-6084. doi: 10.1038/onc.2017.204. Epub 2017 Jul 10.

2.

Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.

Nordeen SK, Bona BJ, Jones DN, Lambert JR, Jackson TA.

Horm Cancer. 2013 Oct;4(5):293-300. doi: 10.1007/s12672-013-0150-1. Epub 2013 Jul 9.

3.

Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.

Zhang C, Nordeen SK, Shapiro DJ.

Methods Mol Biol. 2013;977:339-51. doi: 10.1007/978-1-62703-284-1_27.

4.

8-alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists.

Aninye IO, Berg KC, Mollo AR, Nordeen SK, Wilson EM, Shapiro DJ.

Steroids. 2012 May;77(6):596-601. doi: 10.1016/j.steroids.2012.02.003. Epub 2012 Mar 6.

5.

Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression.

Schaack J, Qiao L, Walkiewicz MP, Stonehouse M, Engel DA, Vazquez-Torres A, Nordeen SK, Shao J, Moorhead JW.

Virology. 2011 Mar 30;412(1):136-45. doi: 10.1016/j.virol.2010.12.053. Epub 2011 Jan 26.

6.

HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.

Axlund SD, Lambert JR, Nordeen SK.

Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.

7.

A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.

Kretzer NM, Cherian MT, Mao C, Aninye IO, Reynolds PD, Schiff R, Hergenrother PJ, Nordeen SK, Wilson EM, Shapiro DJ.

J Biol Chem. 2010 Dec 31;285(53):41863-73. doi: 10.1074/jbc.M110.183723. Epub 2010 Nov 1.

8.

Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.

Zhang Y, Leung DY, Nordeen SK, Goleva E.

J Biol Chem. 2009 Sep 4;284(36):24542-52. doi: 10.1074/jbc.M109.021469. Epub 2009 Jul 8.

9.

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.

Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK.

Mol Cancer Ther. 2009 May;8(5):1055-66. doi: 10.1158/1535-7163.MCT-08-1046. Epub 2009 May 12.

10.

A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.

Mao C, Patterson NM, Cherian MT, Aninye IO, Zhang C, Montoya JB, Cheng J, Putt KS, Hergenrother PJ, Wilson EM, Nardulli AM, Nordeen SK, Shapiro DJ.

J Biol Chem. 2008 May 9;283(19):12819-30. doi: 10.1074/jbc.M709936200. Epub 2008 Mar 12.

11.

Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.

Flaig TW, Nordeen SK, Lucia MS, Harrison GS, Glodé LM.

J Urol. 2007 Apr;177(4):1229-37. Review.

PMID:
17382696
13.

Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.

Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, Eling TE, Lucia MS.

J Cell Physiol. 2006 Sep;208(3):566-74.

PMID:
16741990
14.
15.

Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors.

Blackman B, Russell T, Nordeen SK, Medina D, Neville MC.

Breast Cancer Res. 2005;7(2):R248-55. Epub 2005 Jan 17.

16.

Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions.

Wang SY, Ahn BS, Harris R, Nordeen SK, Shapiro DJ.

Biotechniques. 2004 Nov;37(5):807-8, 810-7.

17.

Novel activation step required for transcriptional competence of progesterone receptor on chromatin templates.

Thackray VG, Toft DO, Nordeen SK.

Mol Endocrinol. 2003 Dec;17(12):2543-53. Epub 2003 Oct 9.

PMID:
14551264
18.

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK.

Cancer Res. 2003 Sep 15;63(18):5879-88.

19.

Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines.

van Bokhoven A, Caires A, Maria MD, Schulte AP, Lucia MS, Nordeen SK, Miller GJ, Varella-Garcia M.

Prostate. 2003 Nov 1;57(3):226-44.

PMID:
14518030
20.

Molecular characterization of human prostate carcinoma cell lines.

van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS.

Prostate. 2003 Nov 1;57(3):205-25.

PMID:
14518029
21.

Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestins.

Wan Y, Nordeen SK.

Recent Prog Horm Res. 2003;58:199-226. Review.

PMID:
12795420
22.

CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.

Lambert JR, Nordeen SK.

Mol Endocrinol. 2003 Jun;17(6):1085-94. Epub 2003 Mar 13.

PMID:
12637584
24.
25.

High-yield purification of functional, full-length steroid receptor coactivator 1 expressed in insect cells.

Thackray VG, Nordeen SK.

Biotechniques. 2002 Feb;32(2):260, 262-3. No abstract available.

PMID:
11848398
26.

Analysis of steroid hormone-induced histone acetylation by chromatin immunoprecipitation assay.

Lambert JR, Nordeen SK.

Methods Mol Biol. 2001;176:273-81. Review. No abstract available.

PMID:
11554328
27.

Application of green fluorescent protein to the study of dynamic protein-protein interactions and subcellular trafficking of steroid receptors.

Nordeen SK, Housley PR, Wan Y, Day RN.

Methods Mol Biol. 2001;176:179-99. Review. No abstract available.

PMID:
11554322
29.

Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.

Schaufele F, Chang CY, Liu W, Baxter JD, Nordeen SK, Wan Y, Day RN, McDonnell DP.

Mol Endocrinol. 2000 Dec;14(12):2024-39.

PMID:
11117532
31.

Estrogen agonist and antagonist action on the human estrogen receptor in Drosophila.

Thackray VG, Young RH, Hooper JE, Nordeen SK.

Endocrinology. 2000 Oct;141(10):3912-5.

PMID:
11014249
32.

Conditional modulation of glucocorticoid receptor activities by CREB-binding protein (CBP) and p300.

Kino T, Nordeen SK, Chrousos GP.

J Steroid Biochem Mol Biol. 1999 Jul-Aug;70(1-3):15-25.

PMID:
10528999
33.

Luciferase reporter gene vectors that lack potential AP-1 sites.

Grimm SL, Nordeen SK.

Biotechniques. 1999 Aug;27(2):220-2. No abstract available.

PMID:
10457818
35.

Visualizing protein-protein interactions in the nucleus of the living cell.

Day RN, Nordeen SK, Wan Y.

Mol Endocrinol. 1999 Apr;13(4):517-26. Review. No abstract available.

PMID:
10194758
37.
38.

Differential gene induction by glucocorticoid and progesterone receptors.

Thackray VG, Lieberman BA, Nordeen SK.

J Steroid Biochem Mol Biol. 1998 Aug;66(4):171-8.

PMID:
9744514
39.

Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning.

Meng X, Brown JM, Ao L, Rowland RT, Nordeen SK, Banerjee A, Harken AH.

Am J Physiol. 1998 Aug;275(2 Pt 1):C475-83.

PMID:
9688602
40.

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.

Boonyaratanakornkit V, Melvin V, Prendergast P, Altmann M, Ronfani L, Bianchi ME, Taraseviciene L, Nordeen SK, Allegretto EA, Edwards DP.

Mol Cell Biol. 1998 Aug;18(8):4471-87.

41.

Extreme position dependence of a canonical hormone response element.

Nordeen SK, Ogden CA, Taraseviciene L, Lieberman BA.

Mol Endocrinol. 1998 Jun;12(6):891-8.

PMID:
9626664
43.
44.

DNA intersegment transfer, how steroid receptors search for a target site.

Lieberman BA, Nordeen SK.

J Biol Chem. 1997 Jan 10;272(2):1061-8.

45.

Cloning, sequencing and proposed structure for a prostaglandin F2 alpha receptor regulatory protein.

Orlicky DJ, Nordeen SK.

Prostaglandins Leukot Essent Fatty Acids. 1996 Oct;55(4):261-8.

PMID:
8951995
46.

Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats.

Meng X, Brown JM, Ao L, Nordeen SK, Franklin W, Harken AH, Banerjee A.

Am J Physiol. 1996 Oct;271(4 Pt 1):C1316-24.

PMID:
8897839
48.

The two faces of a steroid antagonist: when an antagonist isn't.

Nordeen SK, Bona BJ, Beck CA, Edwards DP, Borror KC, DeFranco DB.

Steroids. 1995 Jan;60(1):97-104.

PMID:
7792825
49.
50.

Supplemental Content

Loading ...
Support Center